Ativo Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-67,922
Closed -$7.68M 251
2017
Q2
$7.68M Sell
67,922
-2,110
-3% -$236K 2.1% 5
2017
Q1
$7.01M Sell
70,032
-20,716
-23% -$2.21M 1.74% 8
2016
Q4
$9.76M Sell
90,748
-3,036
-3% -$355K 2.3% 5
2016
Q3
$11.7M Sell
93,784
-290
-0.3% -$34.2K 2.7% 4
2016
Q2
$10M Buy
94,074
+8,451
+10% +$981K 2.44% 5
2016
Q1
$9.8M Sell
85,623
-12,847
-13% -$1.51M 2.66% 5
2015
Q4
$14M Buy
98,470
+4,991
+5% +$576K 3.51% 2
2015
Q3
$10.7M Buy
93,479
+34,378
+58% +$3.63M 2.84% 4
2015
Q2
$7.26M Sell
59,101
-688
-1% -$72.3K 2.56% 7
2015
Q1
$5.71M Buy
59,789
+37,490
+168% +$2.8M 2.24% 7
2014
Q4
$1.5M Buy
22,299
+1,206
+6% +$74.7K 0.62% 60
2014
Q3
$1.14M Buy
21,093
+1,274
+6% +$62.7K 0.45% 63
2014
Q2
$881K Sell
19,819
-3,781
-16% -$154K 0.38% 59
2014
Q1
$820K Sell
23,600
-3,440
-13% -$110K 0.33% 64
2013
Q4
$780K Buy
27,040
+4,294
+19% +$124K 0.34% 64
2013
Q3
$664K Buy
+22,746
New +$567K 0.31% 64

Other funds holding CBPO

Ativo Capital Management's CBPO Position: Q3 2017 in Review

Ativo Capital Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 67,922 shares — an estimated $7.68M sold.

Ativo Capital Management first reported a position in CBPO in Q3 2013 and held it in 16 quarters. The position peaked at $14M in Q4 2015. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

  • Ativo Capital Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
  • Ativo Capital Management sold 67,922 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $7.68M.
  • Ativo Capital Management first reported a position in China Biologic Products Holdings, Inc. in Q3 2013 and held it in 16 quarters.
  • Ativo Capital Management's China Biologic Products Holdings, Inc. position peaked at $14M in Q4 2015.
  • 94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Ativo Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.